Modifi Biosciences is a biotech company that aims to revolutionize cancer treatment by developing a new class of small molecules that directly target DNA, exploiting tumor-associated DNA repair defects. The company's strategy has been validated in vitro and in vivo, and its founding team includes world-renowned scientists, clinicians, and experienced biotech entrepreneurs. The core technology was discovered jointly by Seth Herzon and Ranjit Bindra, who bring deep expertise in synthetic chemistry, DNA repair, and translational research in oncology to the company. Modifi Bio is located in the Elm City BioScience Center, a state-of-the-art facility in the heart of New Haven, CT's burgeoning biotech hub, and is committed to improving the lives of cancer patients.